Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Kancera describes ROR1 inhibitors

Aug. 19, 2016

Galecto Biotech patents galectin 3 ligands

Aug. 19, 2016

Vanderbilt University describes mgluR4 positive allosteric modulators

Aug. 18, 2016

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

Neurocrine Biosciences describes antiepileptic agents

Aug. 17, 2016

Genentech and Constellation Pharmaceuticals disclose TAF1 inhibitors

Aug. 17, 2016

Genentech and Constellation Pharmaceuticals present KDM1A inhibitors

Aug. 17, 2016

Boehringer Ingelheim Pharma patents aldosterone synthase inhibitors

Aug. 17, 2016

Merck & Co. patents potassium channel blockers

Aug. 16, 2016

Takeda Pharmaceutical reports MGAT2 inhibitors

Aug. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...